Navigation Links
Golden Seeds Invests In DxUpClose, Disruptive Technology That Performs An Antibiotic Sensitivity Test At The Patient's Bedside In Less Than An Hour
Date:8/15/2012

DALLAS, Aug. 15, 2012 /PRNewswire/ -- Golden Seeds has invested in a $1.0M Series A financing of DxUpClose. DxUpClose is developing an in-vitro antibiotic sensitivity test for use at point-of-care, designed to deliver results in less than an hour. The first target market is urinary tract infections. Physicians currently do not have real time tools to test antibiotics against bacteria so they have to guess or order expensive lab tests which take 24 to 48 hours for results. Without lab tests, 10% of the time the wrong antibiotic is prescribed. This causes $2.7 billion per year in unnecessary costs due to misdiagnosis and acerbates the growing antibiotic resistance problem. In less than an hour, this bedside test could reduce the guess work and give better results to millions of patients.

The product personalizes medicine by doing three things within one hour at the patient's bedside: list antibiotics proven to be effective against the bacteria, screen for deadly bacteria, and count bacteria present.  The electronic sensor is designed to withstand hot and cold shipping conditions, weigh less than 16 oz and run on batteries.   

"This funding will help us complete the development of the product, enhance sensitivity of the diagnostic, and achieve FDA's design verification milestone" said Cyndi Nickel, DxUpClose's CEO.

"DxUpClose will bring a state of the art diagnostic solution to sufferers of a very painful illness, reduce healthcare costs and assist doctors in providing the best healthcare to their patients", said Jan Norton, Managing Director, Golden Seeds, who co-led the financing and joins the company's board as an observer.

About DxUpClose
DxUpClose was founded in 2009 by Cyndi Nickel, former Hewlett Packard executive in cutting edge technologies.  She combines her business acumen with researchers, inventors and patents from both Texas A&M University and Texas State University to develop a state of the art solution by personalizing medicine to solve a common problem.

About Golden Seeds
Golden Seeds is an investment firm dedicated to delivering above market returns for investors through the empowerment of women entrepreneurs and the people who invest in them. Its angel network consisting of 250 men and women is the fourth largest in the US and was the third most active in terms of deals done in 2011.

CONTACT
Lou Peralta
888-629-6774 x561


'/>"/>
SOURCE Golden Seeds
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Golden Meditech Holdings Limited Announces 2011/ 2012 Annual Results
2. Sentry BioPharma Services Invests in Global Clinical Supply Services with -45C Freezer Expansion
3. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
4. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
5. Global Chiral Technology Industry
6. Antibiotics and Biotechnology Take Center Stage at Food Dialogues Event
7. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
8. Survey: Hospital Executives Nationwide Facing Operating Room Case Volume Increases, Seeking Greater Efficiency through Healthcare Information Technology (HIT)
9. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
10. Leading Medical Technology Company Selects inContact to Transform Service Experience
11. Kam Aims Uses Cloud Technology to Bring Affordable Solution to Freestanding Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... YORK , April 19, 2017 The Mobile ... to showcase a healthy CAGR during the forecast period ... type in the global digital mobile X-Ray devices market, which ... Mn in 2017, expanding at a CAGR of 7% over ... absolute $ opportunity of more than US$ 100 Mn in ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... ... ... A stressful work environment can hurt the physical and emotional health of employees. ... workplace. The goal of Clearview Resolution Services has always been to help others, starting ... will be shutting down the office early on Fridays. The Clearview team will use ...
(Date:4/25/2017)... Lutz, FL (PRWEB) , ... April 25, 2017 , ... ... transform their smiles by using Invisalign® in Lutz, FL. With the help ... oral health and aesthetics with fewer potential complications, more discretion and less pain. ...
(Date:4/25/2017)... ... ... Back Pain Centers of America (BPC), which connects people searching ... area, announces the launch of a new and proprietary customer relationship management (CRM) system ... physicians to help them with back or neck pain and helps to match them ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Emergency Physician ... book of the Outlier Leadership Series, Outliers in Writing, set to publish in summer ... of Emergency Medicine at the University of Arizona College of Medicine. He also serves ...
Breaking Medicine News(10 mins):